
View larger version (49K):
[in a new window]
|
Fig. 4. Fgf signaling is required during early somite stages for first pouch and
hyoid cartilage development. (A-C) Confocal micrographs show Zn8-labeled
pharyngeal pouches (red) and GFP-labeled NCC (green) in fli1-GFP
animals at 34 hpf. Cranial sensory ganglia (dots) also stain with Zn8. In the
wild-type animal (A), an arrowhead marks the first pouch. (B) The first pouch
is variably absent (arrowhead) in fli1-GFP animals upon treatment
with the Fgf receptor antagonist SU5402 from 10-14 hpf. The absence of the
first pouch is selective, as more posterior pouches form normally. (C)
Treatment with SU5402 for 1-hour periods starting from 9-13 hpf (a 10.5-11.5
hpf treatment is shown) produce subtler shape changes of the first pouch
(arrowhead). (D,E) Flat-mount preparations of Alcian-stained pharyngeal
cartilages at 4 days. In wild-type (D), mandibular M and PQ, hyoid CH and HS,
and branchial CB1-5 cartilages are labeled. In those animals in which 10-14
hpf SU5402 treatment caused losses of the first pouch early, the HS cartilage
was selectively absent later (E). Although M, PQ and CH cartilages are reduced
in size, posterior CB cartilages are relatively unaffected. (F) Whereas later
treatments with SU5402 (a 20-21 hpf treatment is shown) do not affect first
pouch development (arrowhead), they do occasionally disrupt the formation of
more posterior pouches (arrow shows an unsegmented branchial NCC mass). (G)
Quantitation of first pouch defects after 4-hour treatments with SU5402. The
percentages of animals with first pouch losses, in black, and misshapen first
pouches, in gray, are plotted. n6-10 hpf=49,
n10-14 hpf=99, n14-18 hpf=21. First
pouch loss after 10-14 hpf treatment is statistically significant using Tukey
HSD test. (H) The percentage of fli1-GFP animals having first pouch
defects (primarily shape changes) plotted against the start time of 1 hour
treatments with SU5402. n5.5 hpf=17, n7
hpf=14, n8 hpf=24, n9 hpf=14,
n10.5 hpf=21, n11 hpf=18,
n12 hpf=26, n13 hpf=26,
n14 hpf=22, n16 hpf=26,
n20 hpf=24, n24 hpf=31. The period of
strongest effect is from 9 hpf (90% epiboly) to 13 hpf (8-somites). In order
to assess the efficiency of inhibition of Fgf signaling, and the recovery
after washout, we fixed sibling controls and examined pea3
expression, a downstream effector of Fgf signaling, at 0 and 4 hours after
washout. We know that SU5402 is at least partially being washed out as
omission of the washout step leads to severe necrosis of animals. For 4-hour
incubation experiments, the levels of pea3 in individual animals,
relative to those in similarly staged untreated controls, were as follows:
6-10 hpf, 6/8 reduced at 10 hpf, 11/13 reduced and 2/13 absent at 14 hpf;
10-14 hpf, 5/13 reduced and 8/13 absent at 14 hpf, 6/13 reduced and 7/13
absent at 18 hpf; 14-18 hpf, 5/12 reduced and 7/12 absent at 18 hpf. As
pea3 levels were similarly reduced at 18 hpf in 10-14 hpf and 14-18
hpf treatments, yet only 10-14 hpf treatments cause first pouch defects, we
conclude that Fgf signaling is required from 10-14 hpf for first pouch
development. However, these experiments do not exclude additional requirements
for Fgf signaling at later times. Anterior is to the left and dorsal is up. M,
Meckel's; PQ, palatoquadrate; CH, ceratohyal; HS, hyosymplectic; SU, SU5402.
Scale bar: 50 µm.
|